These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33244975)

  • 21. Ulcerative colitis or Crohn's colitis. Is differentiation necessary?
    Veidenheimer MC; Nugent FW; Haggitt RC
    Surg Clin North Am; 1976 Jun; 56(3):721-6. PubMed ID: 936019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory bowel disease: the surgical pathology of Crohn's disease and ulcerative colitis.
    Price AB; Morson BC
    Hum Pathol; 1975 Jan; 6(1):7-29. PubMed ID: 1089084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fulminant Crohn's colitis: when only an antibody will do.
    Ng SC; Kamm MA
    Inflamm Bowel Dis; 2007 Aug; 13(8):971-4. PubMed ID: 17427240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness Comparison of Ustekinumab, Infliximab, or Adalimumab for the Treatment of Moderate-Severe Crohn's Disease in Biologic-Naïve Patients.
    Aliyev ER; Hay JW; Hwang C
    Pharmacotherapy; 2019 Feb; 39(2):118-128. PubMed ID: 30565265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgical therapy of severe colitis].
    Seelig MH; Uhlig H; Braun J; Schumpelick V
    Chirurg; 1996 Feb; 67(2):150-4. PubMed ID: 8881212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total colectomy with ileorectal anastomosis in surgical management of toxic megacolon.
    Jamart J; Boissel P; Debs A; Grosdidier J
    Langenbecks Arch Chir; 1983; 360(3):159-65. PubMed ID: 6645727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxic megacolon associated with Crohn's disease.
    Tsuchiya T; Watanabe T; Konishi T; Nagawa H
    Gastrointest Endosc; 2006 Dec; 64(6):1012-3; discussion 1013. PubMed ID: 17140920
    [No Abstract]   [Full Text] [Related]  

  • 29. [Surgical therapy of Crohn disease and ulcerative colitis].
    Schiessel R; Appel W; Rauhs R
    Wien Klin Wochenschr; 1986 Nov; 98(22):769-74. PubMed ID: 3492819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic megacolon.
    Thomford NR
    Surg Annu; 1980; 12():341-50. PubMed ID: 6996173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab in the treatment of ulcerative colitis with toxic megacolon.
    Sriram PV; Reddy KS; Rao GV; Santosh D; Reddy DN
    Indian J Gastroenterol; 2004; 23(1):22-3. PubMed ID: 15106711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic colonic decompression of toxic megacolon, placement of colonic tube, and steroid colonclysis.
    Banez AV; Yamanishi F; Crans CA
    Am J Gastroenterol; 1987 Jul; 82(7):692-4. PubMed ID: 3605033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxic megacolon: ultimate fate of patients after successful medical management.
    Grant CS; Dozois RR
    Am J Surg; 1984 Jan; 147(1):106-10. PubMed ID: 6691535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute toxic dilatation of the colon in Crohn's colitis].
    Shani A; Teva Z; Zikel G; Bernstein D; Horovitz N; Kohn D
    Harefuah; 1975 Dec; 89(11):515-8. PubMed ID: 1205392
    [No Abstract]   [Full Text] [Related]  

  • 35. Fulminant primary manifestation of Crohn's colitis "Hot Crohn's disease".
    Heise W; Kersten O; Kassner KM; Birkenmeyer G; Grosse G; Niedobitek F
    Z Gastroenterol; 1997 Jun; 35(6):481-90. PubMed ID: 9231992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ulcerative colitis and Crohn's disease: indications for surgery and the technical choice].
    Renda A; Coppola L; Landi R
    Minerva Chir; 1985 Mar; 40(5):259-62. PubMed ID: 3991022
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.
    Núñez-Gómez L; Mesonero-Gismero F; Albillos-Martínez A; López-Sanromán A
    Gastroenterol Hepatol; 2018 Nov; 41(9):576-582. PubMed ID: 30054143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical treatment of toxic megacolon].
    Leenen LP; Schoon E; Stuifbergen W; van der Werken C
    Ned Tijdschr Geneeskd; 1991 Jun; 135(22):992-6. PubMed ID: 2062396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn's Disease Patient Successfully Treated with Ustekinumab.
    Bonomo L; de Moll EH; Li L; Geller L; Gordon MI; Dunkin D
    J Drugs Dermatol; 2020 Mar; 19(3):328-331. PubMed ID: 32550694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of toxic dilatation in ulcerative and Crohn's colitis.
    Greenstein AJ; Sachar DB; Gibas A; Schrag D; Heimann T; Janowitz HD; Aufses AH
    J Clin Gastroenterol; 1985 Apr; 7(2):137-43. PubMed ID: 4008909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.